Francois Cedric's Form 4 filing
Apellis Pharmaceuticals, Inc. (APLS) · filed Apr 20, 2023
- Accession no.
- 0001127602-23-013309
- Filed
- Apr 20, 2023
- Trade date
- Apr 18-19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.46M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Francois CedricCIK 0001658080 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | MOption exerciseAcquired | +30,000 | $2.67 | +$80,100 | 667,601 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −30,000 | $82.02 | −$2,460,600 | 637,601 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $2.67 | +$53,400 | 657,601 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 370,000 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 350,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.